P044 Cost-Effectiveness Analysis of Icotinib vs Whole-Brain Irradiation in NSCLC Patients With Brain Metastases

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.067
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.01-127 Efficacy of Endostar Combined With Whole Brain Radiotherapy in Patients With NSCLC Brain Metastases

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Cost Analysis of the Management of Brain Metastases in Patients With Advanced ALK+ NSCLC: Alectinib Versus Crizotinib

Lung Cancer Management
2020English

Efficacy and Safety of Icotinib in Patients With Brain Metastases From Lung Adenocarcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2018English

Whole Brain Irradiation for Metastases From Lung Carcinoma

Acta Radiologica: Oncology
1985English

Concurrent Whole Brain Irradiation With or Without Temozolomide in Treatment of Brain Metastases From Breast Cancer.

International Journal of Advanced Research
2017English

Whole Brain Radiotherapy (WBRT) After Local Treatment of Brain Metastases in Melanoma Patients: Statistical Analysis Plan

Trials
MedicinePharmacology
2019English

MA08.01 Phase 3 Trial of Whole Brain Radiotherapy With Concurrent Erlotinib Versus WBRT Alone for NSCLC With Brain Metastases (ENTER)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy